Scott E. Lazerwith
Impact in
- Virology top 5%
- HIV Research and Treatment
- Toxicology top 2%
- Forensic Toxicology and Drug Analysis
Papers in
-
- Biochemical and Molecular Research 2
-
- Hepatitis B Virus Studies 4
- Liver Disease Diagnosis and Treatment 4
- Co-authors
- Sarah E. Smith (3 shared papers)Cory M. Stiff (3 shared papers)Marya Liimatta (3 shared papers)Benjamin F. Cravatt (3 shared papers)Kay Ahn (3 shared papers)David Beidler (3 shared papers)Douglas S. Johnson (3 shared papers)E. J. Corey (2 shared papers)
- Journals
- Journal of the American Chemical Society (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)Journal of Hepatology (2 papers)Organic Letters (1 paper)ACS Medicinal Chemistry Letters (1 paper)
- Partner nations
- United StatesHong KongCanada
In The Last Decade
Scott E. Lazerwith
14 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 84
- Virology 187
- Toxicology 98
- Pharmacology 465
- Infectious Diseases 239
- Organic Chemistry 248
Countries citing papers authored by Scott E. Lazerwith
This map shows the geographic impact of Scott E. Lazerwith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Lazerwith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Lazerwith more than expected).
Fields of papers citing papers by Scott E. Lazerwith
This network shows the impact of papers produced by Scott E. Lazerwith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Lazerwith. The network helps show where Scott E. Lazerwith may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott E. Lazerwith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 373 | |
| 2 | 2016 | 219 | |
| 3 | 2010 | 148 | |
| 4 | 2005 | 80 | |
| 5 | 2009 | 59 | |
| 6 | 1998 | 53 | |
| 7 | 1997 | 46 | |
| 8 | 2000 | 43 | |
| 9 | 2021 | 25 | |
| 10 | 2013 | 18 | |
| 11 | 2019 | 13 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 3 | |
| 14 | 2017 | 1 |
About Scott E. Lazerwith
Scott E. Lazerwith is a scholar working on Molecular Biology, Epidemiology, Hepatology, Infectious Diseases and Pharmacology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (4 papers), Liver Disease Diagnosis and Treatment (4 papers), HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers), Cannabis and Cannabinoid Research (3 papers), Pancreatic function and diabetes (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Virology (187 citations), Toxicology (98 citations), Pharmacology (465 citations), Infectious Diseases (239 citations) and Organic Chemistry (248 citations). Scott E. Lazerwith has collaborated with scholars based in United States, Hong Kong and Canada. Frequent co-authors include Sarah E. Smith, Cory M. Stiff, Marya Liimatta, Benjamin F. Cravatt, Kay Ahn, David Beidler, Douglas S. Johnson, E. J. Corey, Nalini Sadagopan and Jasmina J. Allen. Their work appears in journals such as Journal of the American Chemical Society, Antimicrobial Agents and Chemotherapy, Journal of Hepatology, Organic Letters and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.